Simpson Thacher Represents Morgan Stanley and Barclays as Financial Advisors to Axiall in Its Announced $3.8 Billion Sale to Westlake Chemical
06.10.16
This is only gets display when printing
Simpson Thacher is representing Morgan Stanley & Co. LLC and Barclays Capital Inc. as financial advisors to Axiall Corporation (NYSE: AXLL) in connection with the announced definitive agreement under which Westlake Chemical Corporation (NYSE: WLK) will acquire all of the outstanding shares of Axiall for $33 per share in an all-cash transaction, representing an enterprise value of approximately $3.8 billion, including debt and certain other Axiall liabilities. The transaction has been unanimously approved by the Boards of Directors of both companies and is expected to be completed by the fourth quarter of 2016, subject to customary closing conditions and the approval of Axiall’s stockholders. The combined company will be the third-largest chlor-alkali producer and the second-largest PVC producer in North America.
Axiall Corporation is a leading integrated chemicals and building products company. Headquartered in Atlanta, Axiall has manufacturing facilities located throughout North America and in Asia to provide industry-leading materials and services to customers.
The Simpson Thacher team included Rob Spatt and Jonathan Stradling (M&A).